Litigation Details for Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2015)

Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2015)

Docket		Date Filed	2015-12-04
Court	Court of Appeals for the Federal Circuit	Date Terminated	2017-05-01
Cause		Assigned To
Jury Demand		Referred To
Patents	6,063,802; 6,132,758; 6,284,770; 6,294,548; 7,947,724; 7,947,725; 7,960,424; 8,518,981; 8,598,219
Link to Docket	External link to docket

Details for Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2015)

Date Filed	Document No.	Description	Snippet	Link To Document
2017-05-01	133		Helsinn owns four patents, U.S. Patent Nos. 7,947,724 (“’724 patent”), 7,947,725 (“’725 patent”), 7,960,…7,960,424 (“’424 patent”), and 8,598,219 (“’219 patent”) (collectively, “the patents-in-suit”), directed…and 9 of the ’724 patent, claim 2 of the ’725 patent, claim 6 of the ’424 patent, and claims 1, 2, …filed a fourth patent application which issued as the ’219 patent. All four patents cover the 0.25 … 9 of the ’724 patent, claim 2 of the ’725 patent, claim 6 of the ’424 patent, and claims 1, 2,	External link to document
0000-00-00	38		Vareg¢ (]T}; Alberto 6,063,802 A 5120~0 Winterbom … 5,922,749, 5,622,720, 5,955,488, and 6,063,802. Commer- …724 patent, claims 2 and 9; ’725 patent, “for reducing emesis or reducing the claim 2; ’424 patent, claim…assignees of U.S. Patents No. 7,947,724 (“‘724 patent”), No. 7,947,725 (“‘725 patent”), No. 7,960,424…7,960,424 (“‘424 patent”), and No. 8,598,219 (“‘219 patent”). The four patents-in-suit are listed in the	External link to document